Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

World Stem Cell Report to be Published in Regenerative Medicine

Published: Thursday, April 14, 2011
Last Updated: Thursday, April 14, 2011
Bookmark and Share
The Genetics Policy Institute (GPI) and Future Medicine have announced that its 2011/12 World Stem Cell Report will be published as a special supplement to the award-winning, peer-reviewed journal Regenerative Medicine.

It was also announced that Regenerative Medicine becomes the platinum media sponsor of the GPI’s 2011 World Stem Cell Summit that will take place in Pasadena, California, October 3-5.

Bernard Siegel, Executive Director of GPI said, “We are proud to partner with the truly superb editorial team at Regenerative Medicine to elevate the World Stem Cell Report to PubMed status. This collaboration will allow the Report to reach an even broader global audience. We will continue to provide an array of specialized articles offering unique insights of leading policy-makers, regulators and experts in law, ethics, advocacy, industry and philanthropy from countries, regions and states. The Report provides a critical unmet need by providing a global framework to understand how the intersection of ethics, law, economics and society impact the advancement of regenerative medicine and the quest for cures.”

Elisa Manzotti, Editorial Director at Future Medicine said “We are delighted to be working with Bernie Siegel and GPI on this exciting collaboration. Our editorial team will take great care to ensure that the World Stem Cell Report articles deliver concise, timely and actionable intelligence to our readers. In becoming a platinum media sponsor of the World Stem Cell Summit, we recognize the Summit’s important role in bringing together leaders from around the globe to chart the future of regenerative medicine.”

The Report will be made available to all attendees at the World Stem Cell Summit. The Summit is the world’s largest interdisciplinary stem cell meeting and is organized this year by GPI, City of Hope, Cedars-Sinai Regenerative Medicine Institute, California Institute of Technology and the California Institute for Regenerative Medicine (CIRM).

The Summit program will feature 170 prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers and experts in law and ethics, who will discuss the latest scientific discoveries, business models, legal and regulatory solutions and best practices.

The Summit is expected to attract more than 2,000 attendees from 25 nations, 60 exhibitors and more than 150 endorsing organizations and media partners.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stem Cells Derived from Amniotic Fluid no Substitute for Embryonic Cells
The GPI welcomes the discovery of versatile stem cells in amniotic fluid as a positive development while cautioning that it does not eliminate the need for embryonic stem cell research.
Wednesday, January 10, 2007
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Unique Visual Stimulation May Be New Treatment for Alzheimer’s
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Major Neuroscience Initiative Launched
Tianqiao and Chrissy Chen Institute invest $115 million to further expand neuroscience research, while Caltech construct $200 million biosciences complex.
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!